Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

By clicking “Deny all”, the default settings of the site will remain active (therefore only technical cookies, necessary for navigation, will be used).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Deny all Show preferences Select all and accept
IMA is loading
Post published on 18/12/2019

The FDA hosts IMA Life to speak on Continuous Freeze Drying

The FDA hosts IMA Life to speak at Scientific Sessions on Continuous Freeze Drying in September and December 2019

For the second time in just three months, the FDA invited IMA Life to present its latest developments on continuous spray freeze drying technologies to an audience of drug evaluation and research professionals.

IMA Life was invited to present the LYnfinity technology on continuous spray freeze drying at the U.S. Food and Drug Administration’s (FDA) main campus in Silver Spring, MD. The session was coordinated through the U.S. FDA’s Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) on September 13, 2019 and December 17, 2019, respectively.

Scientists from the Lab4life lab technology team at IMA Life along with one major pharmaceutical company involved in the testing presented the technology to several FDA scientists and inspectors. The interaction led to several thought provoking questions and discussions around the applications of the technology and the involved validation process. IMA Life and the industry in general very much values such interactions at an early stage to not only improve emerging technology awareness but also for training and feedback. IMA Life is concurrently testing several candidate formulations to identify feasibility for adoption. 

Readers can download product literature by accessing the Lab4Life website here »

Get exclusive insights into the latest innovations in freeze-drying processes and technologies by requesting a reserved access to the Lab4Life Community.

Other Updates

keyboard_arrow_left keyboard_arrow_right